Clinical Trial Update: QUILT-2.013: First-Line Treatment for Extensive Stage Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

This entry reports on the QUILT-2.013 first-line treatment study for extensive-stage small cell lung cancer (Phase 1/2) sponsored by NantCell; the trial is term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Snippet

Sponsor: NantCell, Inc. | Conditions: Lung Cancer, Small Cell Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-08-23